PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15502112-3	2005	We hypothesized that in patients receiving low maintenance dose budesonide/formoterol (bud/form), replacing short-acting beta2-agonist (SABA) reliever with as-needed bud/form would provide rapid symptom relief and simultaneous adjustment in antiinflammatory therapy, thereby reducing exacerbations.	3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole	136-140	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	121-126